A comparison cohort of breast cancers with expected HR defects from PALB2 (n = 15) and RAD51C (n = 9) germline LoF variant carriers, and 115 sporadic breast cancers sequenced using the same platform, were also evaluated. Here, RAD51C is linked to breast cancer.